Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension

M. J. Cork, D. Tha├ži, L. F. Eichenfield, P. D. Arkwright, T. Hultsch, J. D. Davis, Y. Zhang, X. Zhu, Z. Chen, M. Li, M. Ardeleanu, A. Teper, B. Akinlade, A. Gadkari, L. Eckert, M. A. Kamal, M. Ruddy, N. M.H. Graham, G. Pirozzi, N. StahlA. T. DiCioccio, A. Bansal*

*Corresponding author for this work
23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension'. Together they form a unique fingerprint.

Medicine & Life Sciences